Credit: GluCare Diabetes Center
A specialist clinic that’s claiming to be “the world’s first healthcare provider” to “employ remote continuous data monitoring” for diabetic patients has been officially opened in Dubai.
Following a soft launch in September, GluCare Integrated Diabetes Center – which has been developed in the United Arab Emirates (UAE) with partners in Silicon Valley – offers remote continuous data monitoring as...
The smoking-cessation digital-therapeutic app Quit Genius was found to be an effective treatment for people trying to stop smoking, especially when they are compared to individuals seeking out their own regimen, according to new research from JMIR Mental Health.
The results from this study were only indicative for the short term, but researchers noted that a subsequent paper would be published...
New data suggest that an Internet-delivered cognitive behavioral therapy (ICBT) intervention not only remained effective after 12 months among adolescents with obsessive-compulsive disorder, but seemed to have an even greater impact on their symptoms with time.
Published last week in npj digital medicine, the analysis updated a previously reported three-month study with one-year data from the...
It's a bit of a pot pourri this week as the MobiHealthNews team shares some of what it's heard at a variety of (virtual, of course) industry events. First, host Jonah Comstock recaps what Apple announced at its product launch event last week, then Associate Editors Dave Muoio and Mallory Hackett discuss the Digital Therapeutics East event. Last, Managing Editor Laura Lovett and Jonah talk about...
Digital healths’ moment in the sun doesn’t appear to be ending anytime soon, and one area that is just beginning its journey into virtual care is the pharmaceutical industry.
In recent years, pharma has taken an interest in the digital health space, and even before the pandemic hit, experts from HealthXL expected 2020 to be a big year for digital therapeutics in pharma.
This morning at the DTx...
The increased adoption of virtual care technologies during the COVID-19 public health emergency is fairly well documented by this point, but a widespread embrace of health technologies is providing a similar upswell on individual niches within the digital health landscape.
One such group of beneficiaries are the companies working to develop, validate and distribute digital therapeutics. Speaking...
International pharma Boehringer Ingelheim and prescription digital therapeutics company Click Therapeutics have inked a $500 million-plus deal to jointly develop and commercialize a digital treatment for patients with schizophrenia.
The treatment, referred to as CT-155, will be a mobile app built on Click's proprietary tech platform, the companies said.
Employing cognitive and neurobehavioral...
While some of the more obvious barriers to digital therapeutics adoption in Europe have come crashing down recently, adoption is still hampered by cultural momentum. That was the conclusion of a group of digital therapeutics stakeholders who presented at HIMSS & Health 2.0 Europe Digital Event today, in a session moderated by YourCoach Health chairman and COO Eugene Borukhovich.
“Once a...
Biofourmis, a Boston-based predictive-care startup that's leaning more and more into digital therapeutics, has wrapped up $100 million in Series C financing. The raise was led by SoftBank Vision Fund 2, and also saw contributions from prior backers Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI.
With this major jump from last May's $35 million Series B, the company is now...
Pear Therapeutics highlighted data today from two studies of a digital cognitive behavioral therapy that acted as the precursor for Somryst, the prescription digital therapeutic for adults with chronic insomnia that was the first to pass through the FDA's Pre-Cert pilot pathway.
The first, a randomized controlled trial of 1,149 Australian adults with insomnia and depressive symptoms, suggested...
